Maishman Tom, Cutress Ramsey I, Hernandez Aurea, Gerty Sue, Copson Ellen R, Durcan Lorraine, Eccles Diana M
*Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom †Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Ann Surg. 2017 Jul;266(1):165-172. doi: 10.1097/SLA.0000000000001930.
To assess clinical and surgical factors affecting local recurrence and survival in young breast cancer patients in the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH).
Emerging data suggest young age is a predictor of increased local recurrence.
POSH is a prospective cohort of 3024 women of 18 to 40 years with breast cancer. Cohort characteristics were grouped by mastectomy or BCS. Endpoints were local-recurrence interval (LRI), distant disease-free interval (DDFI), and overall survival (OS); described using cumulative-hazard and Kaplan-Meier plots and multivariable analyses by Flexible Parametric and Cox regression models.
Mastectomy was performed in 1464 patients and breast-conserving surgery (BCS) in 1395. Patients undergoing mastectomy had larger tumors and higher proportions of positive family history, estrogen receptor+, progesterone receptor+, and/or human epidermal growth factor receptor 2+ tumors. Local events accounted for 15% of recurrences. LRI by surgical type varied over time with LRI similar at 18 months (1.0% vs 1.0%, P = 0.348) but higher for BCS at 5 and 10 years (5.3% vs 2.6%, P < 0.001; and 11.7% vs 4.9%, P < 0.001, respectively). Similar results were found in the adjusted model. Conversely, distant-metastases and deaths were lower for BCS but not after adjusting for prognostic factors. After mastectomy chest-wall radiotherapy was associated with improved LRI (hazard ratio, HR = 0.46, P = 0.015). Positive surgical margins, and development of local recurrence predicted for reduced DDFI (HR = 0.50, P < 0.001; and HR = 0.29, P = 0.001, respectively).
Surgical extent appears less important for DDFI than completeness of excision or, where appropriate, chest-wall radiotherapy. Despite higher local-recurrence rates for BCS, surgical type does not influence DDFI or OS after adjusting for known prognostic factors in young breast cancer patients.
在散发性与遗传性乳腺癌结局前瞻性研究(POSH)中,评估影响年轻乳腺癌患者局部复发和生存的临床及手术因素。
新出现的数据表明年轻是局部复发增加的一个预测因素。
POSH是一项对3024名年龄在18至40岁的乳腺癌女性进行的前瞻性队列研究。队列特征按乳房切除术或保乳手术进行分组。终点为局部复发间隔时间(LRI)、无远处疾病间隔时间(DDFI)和总生存期(OS);使用累积风险和Kaplan-Meier曲线以及灵活参数和Cox回归模型进行多变量分析来描述。
1464例患者接受了乳房切除术,1395例接受了保乳手术(BCS)。接受乳房切除术的患者肿瘤更大,且有阳性家族史、雌激素受体阳性、孕激素受体阳性和/或人表皮生长因子受体2阳性肿瘤的比例更高。局部事件占复发的15%。不同手术类型的LRI随时间变化,18个月时LRI相似(1.0%对1.0%,P = 0.348),但保乳手术在5年和10年时LRI更高(分别为5.3%对2.6%,P < 0.001;以及11.7%对4.9%,P < 0.001)。在调整模型中发现了类似结果。相反,保乳手术的远处转移和死亡情况较少,但在调整预后因素后并非如此。乳房切除术后胸壁放疗与LRI改善相关(风险比,HR = 0.46,P = 0.015)。手术切缘阳性以及局部复发的发生预示着DDFI降低(分别为HR = 0.50,P < 0.001;以及HR = 0.29,P = 0.001)。
对于DDFI而言,手术范围似乎不如切除的完整性重要,或者在适当情况下不如胸壁放疗重要。尽管保乳手术局部复发率较高,但在调整年轻乳腺癌患者已知的预后因素后,手术类型并不影响DDFI或OS。